XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents, Fair value $ 541,932 $ 966,777
Short-term investments 1,191,610 1,022,597
Accounts receivable 318,855 214,628
Inventory 244,011 203,968
Other current assets 154,441 149,891
Total current assets 2,450,849 2,557,861
Property and equipment, net 212,367 180,037
Right of use assets 133,454 64,954
Non-current inventory 176,112 162,545
Other non-current assets 136,925 162,969
Total assets 3,109,707 3,128,366
Current liabilities:    
Accounts payable 87,948 95,875
Accrued expenses 322,350 418,996
Deferred revenue, current portion 22,494 89,244
Other current liabilities 17,951 15,489
Total current liabilities 450,743 619,604
Long-term debt 1,236,755 1,544,292
Lease liabilities, net of current portion 134,752 57,578
Deferred revenue, net of current portion 485,000 485,000
Contingent consideration 38,100 36,900
Other non-current liabilities 0 42
Total liabilities 2,345,350 2,743,416
Commitments and contingencies (Note 16)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 3,333,333 shares authorized; none issued and outstanding 0 0
Common stock, $0.0001 par value, 198,000,000 shares authorized; 93,537,355 and 87,950,117 issued and outstanding at September 30, 2023, and December 31, 2022, respectively 9 9
Additional paid-in capital 5,256,854 4,296,841
Accumulated other comprehensive loss, net of tax (638) (1,664)
Accumulated deficit (4,491,868) (3,910,236)
Total stockholders’ equity 764,357 384,950
Total liabilities and stockholders’ equity $ 3,109,707 $ 3,128,366